Written by
in
Lina Khan, chair of the Federal Trade Commission, has led a two-year long inquiry into the business … [+] practices of pharmacy benefit managers. The FTC alleges that PBMs have contributed to higher pharmaceutical costs as well as a squeezing…
You must be logged in to post a comment.
Leave a Reply
You must be logged in to post a comment.